Financials
- Market Capitalization 15.46 M
- Employee 8
- Founded 2013
- CEO Murthy Simhambhatla
- Website www.aeonbiopharma.com
- Headquarter Delaware, United States
- FIGI BBG00Z17HDW3
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 4652 | TPST Tempest Therapeutics, Inc. - Common Stock | 1.06 USD | -1.85% | +0.95% | +19.10% | -55.65% | 15.70 M USD | ||
| 4653 | HIND Vyome Holdings, Inc. - Common Stock | 2.21 USD | 0.00% | +0.91% | +7.80% | -74.89% | 15.51 M USD | ||
| 4658 | NCEL NewcelX Ltd. - Ordinary Shares | 3.19 USD | -6.73% | -6.18% | -8.33% | -37.20% | 15.30 M USD | ||
| 4660 | LSTA Lisata Therapeutics, Inc. - Common Stock | 1.69 USD | -7.14% | +3.68% | +56.48% | -25.55% | 15.23 M USD |